Zordix - Lowered near term expectations
2022-12-09 08:18:00
Redeye updates estimates and valuation after Zordix Q3-results which came in below our expectations. While the long-term outlook remains positive with a growing game pipeline, we have lowered our short-term expectations and reduced our estimates. Our new base case stands at SEK32 (SEK46) which is also negatively impacted by increased assumtions for the risk-free rate.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.